Presentation EuroPCR 2013

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Presenter: 203171|Ian Meredith

May 31, 2013

REGISTER for free or LOG IN to view this content

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

DES/BRS/DCB

Presentation

EuroPCR 2013

Up Next

Presentation EuroPCR 2013

One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study

Presenter: 13956|Raul Moreno

May 31, 2013

More slides +

Presentation

What is the Best Initial Management Strategy for Stable Ischemic Heart Disease?

Presenter: 218868|Judith Hochman

May 31, 2013

Presentation EuroPCR 2013

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

Presenter: 228635|John Ormiston

May 31, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.